Cargando…

Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study

BACKGROUND: Fibromyalgia Syndrome and Rheumatoid Arthritis are chronic diseases associated with pain. These diseases reduce the patient’s quality of life and cause psychological problems. The study aimed to determine health anxiety and resilience levels in patients with fibromyalgia syndrome and rhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Karakoyun, Ahmet, Yüksel, Arzu, Bahadır-Yılmaz, Emel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVES 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597064/
https://www.ncbi.nlm.nih.gov/pubmed/36425775
http://dx.doi.org/10.5152/alphapsychiatry.2022.21643
_version_ 1784816010005577728
author Karakoyun, Ahmet
Yüksel, Arzu
Bahadır-Yılmaz, Emel
author_facet Karakoyun, Ahmet
Yüksel, Arzu
Bahadır-Yılmaz, Emel
author_sort Karakoyun, Ahmet
collection PubMed
description BACKGROUND: Fibromyalgia Syndrome and Rheumatoid Arthritis are chronic diseases associated with pain. These diseases reduce the patient’s quality of life and cause psychological problems. The study aimed to determine health anxiety and resilience levels in patients with fibromyalgia syndrome and rheumatoid arthritis during the severe acute respiratory syndrome coronavirus 2 pandemic. METHODS: This case–control study conducted in Central Anatolia Region, Turkey, included 180 participants (60 patients with fibromyalgia syndrome, 60 patients with rheumatoid arthritis, and 60 healthy subjects). Data were collected using the Brief Resilience Scale and Health Anxiety Scale. Pain intensity was assessed using the Visual Analog Scale. RESULTS: Resilience was significantly higher in healthy controls than in the fibromyalgia syndrome and rheumatoid arthritis groups (P < .001). Resilience was also higher in the rheumatoid arthritis group than fibromyalgia syndrome (P < .001) group. Hypersensitivity to somatic symptoms and anxiety, negative results of diseases, and total scores of Health Anxiety Scale were significantly higher in the fibromyalgia syndrome and rheumatoid arthritis groups than healthy controls (P < .001). Also, Health Anxiety Scale scores in the fibromyalgia syndrome group were higher than the rheumatoid arthritis group (P < .001). There was a very strong and negative correlation between the participants’ resilience and health anxiety levels (r = -0.818, P < .001). The most important predictors of resilience were hypersensitivity to somatic symptoms and anxiety (r = -0.335, P < .001), the group (r = 0.302, P = .003), the pain intensity (r = -0.169, P = .043), and the negative consequences of the disease (r = -.149, P = .038). The hypersensitivity to somatic symptoms and anxiety, the Visual Analog Scale, and the negative consequences of the disease were negatively correlated with resilience. But there was a positive correlation between fibromyalgia syndrome and rheumatoid arthritis groups and resilience. CONCLUSIONS: Patients with fibromyalgia syndrome and rheumatoid arthritis have low resilience and high health anxiety. The interventions should be planned to increase resilience and decrease the health anxiety of patients with fibromyalgia syndrome and rheumatoid arthritis.
format Online
Article
Text
id pubmed-9597064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AVES
record_format MEDLINE/PubMed
spelling pubmed-95970642022-11-23 Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study Karakoyun, Ahmet Yüksel, Arzu Bahadır-Yılmaz, Emel Alpha Psychiatry Original Article BACKGROUND: Fibromyalgia Syndrome and Rheumatoid Arthritis are chronic diseases associated with pain. These diseases reduce the patient’s quality of life and cause psychological problems. The study aimed to determine health anxiety and resilience levels in patients with fibromyalgia syndrome and rheumatoid arthritis during the severe acute respiratory syndrome coronavirus 2 pandemic. METHODS: This case–control study conducted in Central Anatolia Region, Turkey, included 180 participants (60 patients with fibromyalgia syndrome, 60 patients with rheumatoid arthritis, and 60 healthy subjects). Data were collected using the Brief Resilience Scale and Health Anxiety Scale. Pain intensity was assessed using the Visual Analog Scale. RESULTS: Resilience was significantly higher in healthy controls than in the fibromyalgia syndrome and rheumatoid arthritis groups (P < .001). Resilience was also higher in the rheumatoid arthritis group than fibromyalgia syndrome (P < .001) group. Hypersensitivity to somatic symptoms and anxiety, negative results of diseases, and total scores of Health Anxiety Scale were significantly higher in the fibromyalgia syndrome and rheumatoid arthritis groups than healthy controls (P < .001). Also, Health Anxiety Scale scores in the fibromyalgia syndrome group were higher than the rheumatoid arthritis group (P < .001). There was a very strong and negative correlation between the participants’ resilience and health anxiety levels (r = -0.818, P < .001). The most important predictors of resilience were hypersensitivity to somatic symptoms and anxiety (r = -0.335, P < .001), the group (r = 0.302, P = .003), the pain intensity (r = -0.169, P = .043), and the negative consequences of the disease (r = -.149, P = .038). The hypersensitivity to somatic symptoms and anxiety, the Visual Analog Scale, and the negative consequences of the disease were negatively correlated with resilience. But there was a positive correlation between fibromyalgia syndrome and rheumatoid arthritis groups and resilience. CONCLUSIONS: Patients with fibromyalgia syndrome and rheumatoid arthritis have low resilience and high health anxiety. The interventions should be planned to increase resilience and decrease the health anxiety of patients with fibromyalgia syndrome and rheumatoid arthritis. AVES 2022-05-01 /pmc/articles/PMC9597064/ /pubmed/36425775 http://dx.doi.org/10.5152/alphapsychiatry.2022.21643 Text en © Copyright 2022 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Karakoyun, Ahmet
Yüksel, Arzu
Bahadır-Yılmaz, Emel
Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study
title Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study
title_full Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study
title_fullStr Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study
title_full_unstemmed Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study
title_short Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study
title_sort determination of health anxiety and resilience levels in patients with fibromyalgia syndrome and rheumatoid arthritis during sars-cov-2 pandemic: a case–control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597064/
https://www.ncbi.nlm.nih.gov/pubmed/36425775
http://dx.doi.org/10.5152/alphapsychiatry.2022.21643
work_keys_str_mv AT karakoyunahmet determinationofhealthanxietyandresiliencelevelsinpatientswithfibromyalgiasyndromeandrheumatoidarthritisduringsarscov2pandemicacasecontrolstudy
AT yukselarzu determinationofhealthanxietyandresiliencelevelsinpatientswithfibromyalgiasyndromeandrheumatoidarthritisduringsarscov2pandemicacasecontrolstudy
AT bahadıryılmazemel determinationofhealthanxietyandresiliencelevelsinpatientswithfibromyalgiasyndromeandrheumatoidarthritisduringsarscov2pandemicacasecontrolstudy